Jennifer Hodge

Jennifer Hodge PhD serves as the VP of Evidence Generation in Medical Affairs at BridgeBio, a position held since November 2023. Prior to this role, Jennifer held various leadership positions at Pfizer from May 2012 to November 2023, including USMA Team Lead for Rare Neurology/Endocrine, US DMD Lead, Early Pipeline/Gene Therapy Lead for North America Medical Affairs in Rare Disease, and Senior Director roles in Global Medical Affairs for Rare Disease and Hemophilia. Previously, Jennifer was the VP and Medical Director at IMSci, and Associate Medical Director at BGB Group. Early in the career, Jennifer contributed as an Associate Research Scientist at Yale University School of Medicine and as a Post-Doctoral Fellow at Massachusetts General Hospital. Educational qualifications include a PhD in Immunology from the University of Pennsylvania School of Medicine and a BS from Worcester Polytechnic Institute.